Home LiteratureArticle Details
PMID: 10611369 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities.

Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarollo L

Abstract

Brain-derived neurotrophic factor (BDNF) has trophic effects on serotonergic (5-HT) neurons in the central nervous system. However, the role of endogenous BDNF in the development and function of these neurons has not been established in vivo because of the early postnatal lethality of BDNF null mice. In the present study, we use heterozygous BDNF(+/-) mice that have a normal life span and show that these animals develop enhanced intermale aggressiveness and hyperphagia accompanied by significant weight gain in early adulthood; these behavioral abnormalities are known to correlate with 5-HT dysfunction. Forebrain 5-HT levels and fiber density in BDNF(+/-) mice are normal at an early age but undergo premature age-associated decrements. However, young adult BDNF(+/-) mice show a blunted c-fos induction by the specific serotonin releaser-uptake inhibitor dexfenfluramine and alterations in the expression of several 5-HT receptors in the cortex, hippocampus, and hypothalamus. The heightened aggressiveness can be ameliorated by the selective serotonin reuptake inhibitor fluoxetine. Our results indicate that endogenous BDNF is critical for the normal development and function of central 5-HT neurons and for the elaboration of behaviors that depend on these nerve cells. Therefore, BDNF(+/-) mice may provide a useful model to study human psychiatric disorders attributed to dysfunction of serotonergic neurons.

MeSH Terms
Aggression Animals Behavior, Animal Brain/physiopathology Brain-Derived Neurotrophic Factor/deficiency,genetics Dexfenfluramine/pharmacology Female Heterozygote Hyperphagia Male Mice Mice, Mutant Strains Proto-Oncogene Proteins c-fos/biosynthesis Serotonin/metabolism
Chemicals
Brain-Derived Neurotrophic Factor Proto-Oncogene Proteins c-fos Serotonin Dexfenfluramine
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Lyons W E
Neural Development Group, Advanced BioScience Laboratories/Basic Research Program, National Cancer Institute/Frederick Cancer Research and Development Center, Frederick, MD 21702, USA.
Mamounas L A
Ricaurte G A
Coppola V
Reid S W
Bora S H
Wihler C
Koliatsos V E
Tessarollo L
References (42)
42 references, click to expand
  1. Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization.
    Dev Biol. 1995 Jul;170(1):169-82 PMID: 7601307
  2. The Open-Field Test: a critical review.
    Psychol Bull. 1976 May;83(3):482-504 PMID: 17582919
  3. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor.
    Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8856-60 PMID: 7568031
  4. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord.
    Exp Neurol. 1995 Aug;134(2):261-72 PMID: 7556546
  5. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain.
    J Neurosci. 1995 Dec;15(12):7929-39 PMID: 8613731
  6. Mean genes.
    Neuron. 1996 Jan;16(1):17-21 PMID: 8562081
  7. Psychopharmacology of central serotonergic systems.
    Pharmacopsychiatry. 1995 Oct;28 Suppl 2:73-9 PMID: 8614704
  8. Serotonin receptors and animal models of aggressive behavior.
    Pharmacopsychiatry. 1995 Oct;28 Suppl 2:80-90 PMID: 8614705
  9. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration.
    Brain Res. 1996 Feb 26;710(1-2):11-20 PMID: 8963648
  10. Serotonergic control of the organization of feeding and satiety.
    Behav Brain Res. 1996;73(1-2):37-42 PMID: 8788474
  11. The influence of fluoxetine on aggressive behavior.
    Neuropsychopharmacology. 1996 Feb;14(2):77-81 PMID: 8822529
  12. Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats.
    Br J Pharmacol. 1996 Nov;119(5):845-50 PMID: 8922730
  13. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).
    Pharmacol Biochem Behav. 1997 Jan;56(1):131-7 PMID: 8981620
  14. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability.
    Trends Pharmacol Sci. 1997 Jan;18(1):21-5 PMID: 9114726
  15. The serotonin hypothesis of aggression revisited.
    Clin Psychol Rev. 1997;17(6):651-65 PMID: 9336689
  16. Absence of sensory neurons before target innervation in brain-derived neurotrophic factor-, neurotrophin 3-, and TrkC-deficient embryonic mice.
    J Neurosci. 1997 Dec 1;17(23):9113-21 PMID: 9364058
  17. Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat.
    Exp Neurol. 1997 Dec;148(2):475-94 PMID: 9417827
  18. Expression of c-fos protein in brain: metabolic mapping at the cellular level.
    Science. 1988 Jun 3;240(4857):1328-31 PMID: 3131879
  19. Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex.
    Brain Res. 1988 Jun 21;453(1-2):315-28 PMID: 3401769
  20. Brain 5-HT1 binding sites in depressed suicides.
    Psychopharmacology (Berl). 1990;102(4):544-8 PMID: 2096412
  21. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    J Pharmacol Exp Ther. 1992 May;261(2):616-22 PMID: 1374470
  22. Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function.
    Br J Psychiatry. 1992 May;160:643-6 PMID: 1591573
  23. Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism.
    Trends Neurosci. 1992 Dec;15(12):491-7 PMID: 1282749
  24. Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats.
    Brain Res Bull. 1993;31(1-2):43-8 PMID: 8453494
  25. Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes.
    Eur J Pharmacol. 1993 Jul 6;238(1):9-17 PMID: 8405087
  26. Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3.
    Brain Res. 1994 Jan 7;633(1-2):326-30 PMID: 7511037
  27. Mice lacking brain-derived neurotrophic factor develop with sensory deficits.
    Nature. 1994 Mar 10;368(6467):147-50 PMID: 8139657
  28. Buspirone's efficacy in organic-induced aggression.
    J Clin Psychopharmacol. 1994 Apr;14(2):126-30 PMID: 8195453
  29. Enhanced aggressive behavior in mice lacking 5-HT1B receptor.
    Science. 1994 Sep 23;265(5180):1875-8 PMID: 8091214
  30. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
    Pharmacol Rev. 1994 Jun;46(2):157-203 PMID: 7938165
  31. Activity-dependent and hormonal regulation of neurotrophin mRNA levels in the brain--implications for neuronal plasticity.
    J Neurobiol. 1994 Nov;25(11):1362-72 PMID: 7852991
  32. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.
    J Neurosci. 1995 Mar;15(3 Pt 1):1768-77 PMID: 7891134
  33. Characteristics of BDNF-induced weight loss.
    Exp Neurol. 1995 Feb;131(2):229-38 PMID: 7534721
  34. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors.
    Nature. 1995 Apr 6;374(6522):542-6 PMID: 7700379
  35. The neurobiology of suicide.
    Nat Med. 1998 Jan;4(1):25-30 PMID: 9427602
  36. p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions.
    Brain Res. 1997 Nov 7;774(1-2):94-105 PMID: 9452197
  37. Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice.
    J Neurosci. 1998 Jul 15;18(14):5537-44 PMID: 9651234
  38. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene.
    Nat Med. 1998 Oct;4(10):1152-6 PMID: 9771748
  39. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors.
    J Neurosci. 1998 Dec 1;18(23):10150-6 PMID: 9822768
  40. A role for BDNF in mechanosensation.
    Nat Neurosci. 1998 May;1(1):42-6 PMID: 10195107
  41. Brain-derived neurotrophic factor levels in the nervous system of wild-type and neurotrophin gene mutant mice.
    J Neurochem. 1999 May;72(5):1930-8 PMID: 10217270
  42. Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans?
    Pharmacol Ther. 1995 Apr;66(1):17-37 PMID: 7630928
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1999-12-21
Pages
15239-44
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC24804
Subset
IM
Grants
NIMH NIH HHS · F32 MH085433 · United States
NINDS NIH HHS · F32 NS010580 · United States
NINDS NIH HHS · NS 10580 · United States
NIMH NIH HHS · R29MH85433 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com